{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T01:10:46Z","timestamp":1788311446599,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Foundation of Korea,South Korea","award":["2021R1C1C2009542"],"award-info":[{"award-number":["2021R1C1C2009542"]}]},{"name":"National Research Foundation of Korea,South Korea","award":["2021R1C1C2095327"],"award-info":[{"award-number":["2021R1C1C2095327"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Complement Med Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cardio-Renal Metabolic Syndrome (CRS) encompasses metabolic disorders such as type 2 diabetes, hypertension, hyperlipidemia, chronic kidney disease, and heart failure. It is associated with obesity, systemic inflammation, and insulin resistance.\n                      <jats:italic>Atractylodes lancea<\/jats:italic>\n                      (AL), a traditional herbal remedy, has been previously reported to exhibit diuretic, sedative, antibacterial, and anticancer effects. However, the impact of AL on cardiovascular and renal functions within a metabolic syndrome (MS) model remains to be explored.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Metabolic syndrome was induced in rats through an 8-week high-fat, high-fructose diet. After induction, experimental groups were orally administered olmesartan (10\u00a0mg\/kg\/day) or Aqueous extract of\n                      <jats:italic>Atractylodes lancea<\/jats:italic>\n                      (AAL) at 100 or 200\u00a0mg\/kg\/day for an additional 8 weeks. Body weight, fasting blood glucose, triglycerides, abdominal circumference, systolic blood pressure, and HDL-cholesterol levels were measured. Insulin levels and oral glucose tolerance tests (OGTT) were conducted to evaluate insulin resistance. Cardiac function was assessed using echocardiography, and ejection fraction and fractional shortening were analyzed. Masson\u2019s trichrome and Picrosirius red staining were performed to evaluate fibrosis in the heart and aorta. Renal function was measured through creatinine clearance, blood urea nitrogen (BUN), and electrolyte levels. Periodic acid-Schiff (PAS) staining was additionally performed to evaluate histological changes in the kidney.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Administration of AAL resulted in significant reductions in body weight, fasting blood glucose, triglycerides, abdominal circumference, and systolic blood pressure, while HDL-cholesterol levels increased. AAL improved insulin resistance, as indicated by enhanced insulin levels and OGTT results. Echocardiography revealed improvements in ejection fraction and fractional shortening in AAL-treated groups compared to the MS group. Histological analysis showed that AAL reduced heart and aorta fibrosis, as well as attenuated kidney injury. Additionally, AAL improved renal function by enhancing creatinine clearance, reducing BUN levels, and stabilizing electrolyte balance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The aqueous extract of\n                      <jats:italic>Atractylodes lancea<\/jats:italic>\n                      (AAL) effectively ameliorated cardiovascular and renal dysfunction in a rat model of metabolic syndrome model. These results suggest that AAL may have preventive and therapeutic potential for cardio-renal complications associated with MS. However, further investigation is needed to evaluate its suitability for diet-based interventions and evaluate its safety and pharmacological profile.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12906-025-05074-8","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:56:00Z","timestamp":1759229760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Therapeutic potential of Atractylodes lancea in restoring cardio-renal function in rats with diet-induced metabolic syndrome"],"prefix":"10.1186","volume":"25","author":[{"given":"Yun Jeong","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Hyeon","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung Joo","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai Lin","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Sub","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Joo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Yoom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Gill","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"issue":"2","key":"5074_CR1","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s11906-012-0254-y","volume":"14","author":"RM Tanner","year":"2012","unstructured":"Tanner RM, Brown TM, Muntner P. Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep. 2012;14(2):152\u20139.","journal-title":"Curr Hypertens Rep"},{"key":"5074_CR2","doi-asserted-by":"publisher","first-page":"m696","DOI":"10.1136\/bmj.m696","volume":"369","author":"L Ge","year":"2020","unstructured":"Ge L, Sadeghirad B, Ball GDC, da Costa BR, Hitchcock CL, Svendrovski A, Kiflen R, Quadri K, Kwon HY, Karamouzian M, Adams-Webber T, Ahmed W, Damanhoury S, Zeraatkar D, Nikolakopoulou A, Tsuyuki RT, Tian J, Yang K, Guyatt GH, Johnston BC. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ. 2020;369:m696.","journal-title":"BMJ"},{"issue":"2","key":"5074_CR3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.ecl.2004.03.005","volume":"33","author":"AJ Cameron","year":"2004","unstructured":"Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351\u201375.","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"1","key":"5074_CR4","first-page":"15","volume":"18","author":"V Blaton","year":"2007","unstructured":"Blaton V. How is the metabolic syndrome related to the dyslipidemia?? EJIFCC. 2007;18(1):15\u201322.","journal-title":"EJIFCC"},{"issue":"1","key":"5074_CR5","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13098-018-0365-y","volume":"10","author":"LP Antoniolli","year":"2018","unstructured":"Antoniolli LP, Nedel BL, Pazinato TC, de Andrade Mesquita L, Gerchman F. Accuracy of insulin resistance indices for metabolic syndrome: a cross-sectional study in adults. Diabetol Metab Syndr. 2018;10(1):65.","journal-title":"Diabetol Metab Syndr"},{"key":"5074_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12986-016-0074-1","volume":"13","author":"L Lozano","year":"2016","unstructured":"Lozano L, Werf RV, Bietiger W, Seyfritz E, Peronet C, Pinget M, Jeandidier N, Maillard E, Marchioni E, Sigrist S, Dal S. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond). 2016;13:15.","journal-title":"Nutr Metab (Lond)"},{"issue":"10","key":"5074_CR7","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1161\/01.CIR.0000140677.20606.0E","volume":"110","author":"S Malik","year":"2004","unstructured":"Malik S, Wong ND, Franklin SS, Kamath TV, L\u2019Italien GJ, Pio JR, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation. 2004;110(10):1245\u201350.","journal-title":"Circulation"},{"key":"5074_CR8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000506899","volume":"3","author":"MM Farag","year":"2020","unstructured":"Farag MM, Ashour EH, El-Hadidy WF. Amelioration of high fructose diet-induced insulin resistance, hyperuricemia, and liver oxidative stress by combined use of selective agonists of PPAR-a and PPAR-y in rats. Dubai Med J. 2020;3:76\u201386.","journal-title":"Dubai Med J"},{"issue":"2","key":"5074_CR9","first-page":"19","volume":"26","author":"G Wilcox","year":"2005","unstructured":"Wilcox G. Insulin and insulin resistance. Clin Biochem Rev. 2005;26(2):19\u201339.","journal-title":"Clin Biochem Rev"},{"issue":"6","key":"5074_CR10","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jacc.2005.11.046","volume":"47","author":"SM Grundy","year":"2006","unstructured":"Grundy SM. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol. 2006;47(6):1093\u2013100.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"5074_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0006-8993(92)90101-E","volume":"575","author":"H Nojima","year":"1992","unstructured":"Nojima H, Kimura I, Kimura M. Blocking action of succinylcholine with beta-eudesmol on acetylcholine-activated channel activity at endplates of single muscle cells of adult mice. Brain Res. 1992;575(2):337\u201340.","journal-title":"Brain Res"},{"key":"5074_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/j.2040-4603.2013.tb00484.x","volume":"3","author":"CK Roberts","year":"2013","unstructured":"Roberts CK, Hevener AL, Barnard RJ. Metabolic syndrome and insulin resistance: underlying causes and modification by exercise training. Compr Physiol. 2013;3:1\u201358.","journal-title":"Compr Physiol"},{"issue":"4","key":"5074_CR13","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","volume":"122","author":"G Jia","year":"2018","unstructured":"Jia G, Hill MA, Sowers JR. Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity. Circ Res. 2018;122(4):624\u201338.","journal-title":"Circ Res"},{"issue":"5","key":"5074_CR14","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.recesp.2010.11.011","volume":"64","author":"MF Landecho","year":"2011","unstructured":"Landecho MF, Colina I, Huerta A, Fortu\u00f1o A, Zalba G, Beloqui O. Relaci\u00f3n entre Las fases precoces de La enfermedad renal y El s\u00edndrome metab\u00f3lico [Connection between the early phases of kidney disease and the metabolic syndrome]. Rev Esp Cardiol. 2011;64(5):373\u20138.","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"5074_CR15","doi-asserted-by":"publisher","first-page":"155","DOI":"10.15171\/bi.2015.13","volume":"5","author":"G Li Cavoli","year":"2015","unstructured":"Li Cavoli G, Passantino R, Ferrantelli A, Tralongo A, Servillo F, Li Cavoli TV, Tralongo P, Palmeri M, Ferrantelli G, Ugo R. Acute kidney injury in a patient with metabolic syndrome. Bioimpacts. 2015;5(3):155\u20137.","journal-title":"Bioimpacts"},{"issue":"1","key":"5074_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000187881","volume":"67","author":"C Guijarro","year":"1994","unstructured":"Guijarro C, Keane WF. Lipid-induced glomerular injury. Nephron. 1994;67(1):1\u20136.","journal-title":"Nephron"},{"issue":"12","key":"5074_CR17","doi-asserted-by":"publisher","first-page":"3438","DOI":"10.1681\/ASN.2006080944","volume":"17","author":"M Nagase","year":"2006","unstructured":"Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol. 2006;17(12):3438\u201346.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"5074_CR18","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","volume":"22","author":"M Marassi","year":"2023","unstructured":"Marassi M, Fadini GP. The cardio-renal-metabolic connection: a review of the evidence. Cardiovasc Diabetol. 2023;22(1):195. Published 2023 Jul 31.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"5074_CR19","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/jor.24016","volume":"36","author":"Z Jiang","year":"2018","unstructured":"Jiang Z, Lu W, Zeng Q, Li D, Ding L, Wu J. High glucose-induced excessive reactive oxygen species promote apoptosis through mitochondrial damage in rat cartilage endplate cells. J Orthop Res. 2018;36(9):2476\u201383.","journal-title":"J Orthop Res"},{"issue":"11","key":"5074_CR20","doi-asserted-by":"publisher","first-page":"9352","DOI":"10.3390\/ijms24119352","volume":"24","author":"P Gonz\u00e1lez","year":"2023","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11):9352. Published 2023 May 27.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"5074_CR21","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.3390\/ijms24065241","volume":"24","author":"B Mart\u00edn-Carro","year":"2023","unstructured":"Mart\u00edn-Carro B, Mart\u00edn-V\u00edrgala J, Fern\u00e1ndez-Villabrille S, et al. Role of Klotho and AGE\/RAGE-Wnt\/\u03b2-Catenin signalling pathway on the development of cardiac and renal fibrosis in diabetes. Int J Mol Sci. 2023;24(6):5241. Published 2023 Mar 9.","journal-title":"Int J Mol Sci"},{"issue":"8","key":"5074_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.arcmed.2013.11.002","volume":"44","author":"P Leurs","year":"2013","unstructured":"Leurs P, Lindholm B. The AGE-RAGE pathway and its relation to cardiovascular disease in patients with chronic kidney disease. Arch Med Res. 2013;44(8):601\u201310.","journal-title":"Arch Med Res"},{"issue":"8","key":"5074_CR23","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.3390\/biomedicines12081802","volume":"12","author":"SM Stanciu","year":"2024","unstructured":"Stanciu SM, Jinga M, Miricescu D, et al. mTOR dysregulation, insulin resistance, and hypertension. Biomedicines. 2024;12(8):1802. Published 2024 Aug 8.","journal-title":"Biomedicines"},{"key":"5074_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2013.00161","volume":"4","author":"AR Aroor","year":"2013","unstructured":"Aroor AR, Demarco VG, Jia G, et al. The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness. Front Endocrinol (Lausanne). 2013;4:161.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"5074_CR25","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.3390\/nu11071664","volume":"11","author":"H Nishi","year":"2019","unstructured":"Nishi H, Higashihara T, Inagi R. Lipotoxicity in kidney, heart, and skeletal muscle dysfunction. Nutrients. 2019;11(7):1664. Published 2019 Jul 20.","journal-title":"Nutrients"},{"issue":"5","key":"5074_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.3390\/biomedicines12050978","volume":"12","author":"JA D\u2019Elia","year":"2024","unstructured":"D\u2019Elia JA, Weinrauch LA. Lipid toxicity in the Cardiovascular-Kidney-Metabolic syndrome (CKMS). Biomedicines. 2024;12(5):978. Published 2024 Apr 29.","journal-title":"Biomedicines"},{"key":"5074_CR27","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3109\/00365516009065404","volume":"12","author":"E Raabo","year":"1960","unstructured":"Raabo E, Terkildsen TC. On the enzymatic determination of blood glucose. Scand J Clin Lab Invest. 1960;12:402\u20137.","journal-title":"Scand J Clin Lab Invest"},{"issue":"5","key":"5074_CR28","first-page":"544","volume":"33","author":"HK Han","year":"2020","unstructured":"Han HK, Choi EY. Effects of atractylodes lancea on plasma glucose and lipid profile in streptozotocin induced diabetic rats. Korean J Food Nutr. 2020;33(5):544\u201350.","journal-title":"Korean J Food Nutr"},{"issue":"1","key":"5074_CR29","first-page":"934","volume":"495","author":"HJ Kim","year":"2018","unstructured":"Kim HJ, Han J, Shin YK, Kang SS. Modulatory effects of atractylone on AMPK signaling in adipocytes. Biochem Biophys Res Commun. 2018;495(1):934\u201340.","journal-title":"Biochem Biophys Res Commun"},{"key":"5074_CR30","volume":"83","author":"T Zhao","year":"2020","unstructured":"Zhao T, Tang H, Xie L, Zheng Y. Inhibitory effects of sesquiterpenoids from atractylodes lancea on inflammatory responses in RAW264.7 cells. Int Immunopharmacol. 2020;83:106475.","journal-title":"Int Immunopharmacol"},{"key":"5074_CR31","volume":"267","author":"Y Li","year":"2021","unstructured":"Li Y, Chen J, Xiong Y, Wang J, Xu Y. Atractylone suppresses LPS-induced inflammation by inhibiting NF-\u03baB signaling in macrophages. J Ethnopharmacol. 2021;267:113545.","journal-title":"J Ethnopharmacol"},{"issue":"5","key":"5074_CR32","first-page":"360","volume":"19","author":"LK Han","year":"2005","unstructured":"Han LK, Zheng YN, Xu BJ, Okuda H, Kimura Y. Anti-obesity effects of crude drugs from traditional Chinese medicine on mice fed a high-fat diet. Phytother Res. 2005;19(5):360\u20135.","journal-title":"Phytother Res"},{"issue":"5","key":"5074_CR33","first-page":"411","volume":"61","author":"S Yamamoto","year":"2015","unstructured":"Yamamoto S, Nagata S, Yamashita Y, Tsuji A, Tani T. Effects of atractylodes lancea extracts on glucose tolerance in obese mice. J Nutr Sci Vitaminol (Tokyo). 2015;61(5):411\u20137.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"key":"5074_CR34","doi-asserted-by":"crossref","first-page":"111293","DOI":"10.1016\/j.biopha.2021.111293","volume":"137","author":"X Zhou","year":"2021","unstructured":"Zhou X, Xiao X, Wang Z, Cai J. Hepatoprotective effects of atractylone on non-alcoholic fatty liver disease in mice by attenuating oxidative stress and inflammation. Biomed Pharmacother. 2021;137:111293.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"5074_CR35","doi-asserted-by":"publisher","first-page":"e95","DOI":"10.3346\/jkms.2021.36.e95","volume":"34","author":"KH Park","year":"2019","unstructured":"Park KH, Kim HK, Lee SH, Jung DH, Kim JB. Blood pressure-lowering effects of atractylodes lancea in spontaneously hypertensive rats. J Korean Med Sci. 2019;34(12):e95.","journal-title":"J Korean Med Sci"},{"key":"5074_CR36","volume":"7","author":"W Cai","year":"2020","unstructured":"Cai W, Zhang K, Li P, He H, Tan Y. Sesquiterpenoids from Atractylodes lancea improve myocardial function by attenuating oxidative damage. Front Cardiovasc Med. 2020;7:30.","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"5074_CR37","first-page":"233","volume":"148","author":"X Wang","year":"2022","unstructured":"Wang X, Song Y, Zhang Y, Wang S. Cardioprotective effects of atractylone on myocardial ischemia-reperfusion injury via modulation of PI3K\/Akt signaling pathway. J Pharmacol Sci. 2022;148(3):233\u201342.","journal-title":"J Pharmacol Sci"},{"key":"5074_CR38","doi-asserted-by":"crossref","first-page":"112646","DOI":"10.1016\/j.jep.2020.112614","volume":"253","author":"J Wang","year":"2020","unstructured":"Wang J, Chen Y, Zhao Z, Shi S. Atractylone alleviates renal fibrosis by regulating TGF-\u03b2\/Smad signaling in a rat model of renal fibrosis. J Ethnopharmacol. 2020;253:112646.","journal-title":"J Ethnopharmacol"},{"key":"5074_CR39","volume":"91","author":"D Liu","year":"2021","unstructured":"Liu D, Zhang J, Xie Y, Wu L. Anti-inflammatory and diuretic effects of atractylodes lancea extract in animal models of acute kidney injury. Phytomedicine. 2021;91:153695.","journal-title":"Phytomedicine"},{"issue":"1","key":"5074_CR40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12906-020-2854-4","volume":"20","author":"H Sun","year":"2020","unstructured":"Sun H, Liu Z, Wu M, Guo Q. Protective effects of atractylodes lancea on acute kidney injury by reducing inflammatory cytokines and oxidative stress in rats. BMC Complement Altern Med. 2020;20(1):65.","journal-title":"BMC Complement Altern Med"},{"issue":"2","key":"5074_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118135","volume":"10","author":"O Wang","year":"2015","unstructured":"Wang O, Liu J, Cheng Q, Guo X, Wang Y, Zhao L, Zhou F, Ji B. Effects of ferulic acid and \u03b3-oryzanol on high-fat and high-fructose diet-induced metabolic syndrome in rats. PLoS One. 2015;10(2): e0118135.","journal-title":"PLoS One"},{"issue":"4","key":"5074_CR42","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1021\/acs.jafc.5b04715","volume":"64","author":"J Zhang","year":"2016","unstructured":"Zhang J, Wang O, Guo Y, Wang T, Wang S, Li G, et al. Effect of increasing doses of linoleic and \u03b1-linolenic acids on high-fructose and high-fat diet induced metabolic syndrome in rats. J Agric Food Chem. 2016;64(4):762\u201372.","journal-title":"J Agric Food Chem"},{"key":"5074_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.podrm.2017.02.005","volume":"42","author":"AA Al-Majed","year":"2017","unstructured":"Al-Majed AA, Bakheit AHH, Abdel Aziz HA, Al-Jallal AAM. Olmesartan Profiles Drug Subst Excip Relat Methodol. 2017;42:241\u201386.","journal-title":"Olmesartan Profiles Drug Subst Excip Relat Methodol"},{"issue":"7","key":"5074_CR44","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412\u20139.","journal-title":"Diabetologia"},{"issue":"9","key":"5074_CR45","doi-asserted-by":"publisher","first-page":"641","DOI":"10.7326\/0003-4819-121-9-199411010-00002","volume":"121","author":"B Kinosian","year":"1994","unstructured":"Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Ann Intern Med. 1994;121(9):641\u20137.","journal-title":"Ann Intern Med"},{"issue":"9468","key":"5074_CR46","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365(9468):1415\u201328.","journal-title":"Lancet"},{"issue":"1","key":"5074_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.26502\/fccm.92920302","volume":"7","author":"D Singh","year":"2023","unstructured":"Singh D, Rai V, Agrawal DK. Regulation of collagen I and collagen III in tissue injury and regeneration. Cardiol Cardiovasc Med. 2023;7(1):5\u201316.","journal-title":"Cardiol Cardiovasc Med"},{"issue":"5","key":"5074_CR48","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1559-4564.2006.05626.x","volume":"1","author":"MR Hayden","year":"2006","unstructured":"Hayden MR, Chowdhury N, Govindarajan G, Karuparthi PR, Habibi J, Sowers JR. Myocardial myocyte remodeling and fibrosis in the cardiometabolic syndrome. J Cardiometab Syndr. 2006;1(5):326\u201333.","journal-title":"J Cardiometab Syndr"},{"issue":"5","key":"5074_CR49","doi-asserted-by":"publisher","first-page":"F919","DOI":"10.1152\/ajprenal.00068.2011","volume":"301","author":"A Odermatt","year":"2011","unstructured":"Odermatt A. The western-style diet: a major risk factor for impaired kidney function and chronic kidney disease. Am J Physiol-Renal Physiol. 2011;301(5):F919-31.","journal-title":"Am J Physiol-Renal Physiol"},{"issue":"10","key":"5074_CR50","doi-asserted-by":"publisher","first-page":"e10896","DOI":"10.1016\/j.heliyon.2022.e10896","volume":"8","author":"I Yustisia","year":"2022","unstructured":"Yustisia I, Tandiari D, Cangara MH, Hamid F, Daud NA. A high-fat, high-fructose diet induced hepatic steatosis, renal lesions, dyslipidemia, and hyperuricemia in non-obese rats. Heliyon. 2022;8(10):e10896.","journal-title":"Heliyon"},{"key":"5074_CR51","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/1476-511X-12-136","volume":"12","author":"UG de Castro","year":"2013","unstructured":"de Castro UG, dos Santos RA, Silva ME, de Lima WG, Campagnole-Santos MJ, Alzamora AC. Age-dependent effect of high-fructose and high-fat diets on lipid metabolism and lipid accumulation in liver and kidney of rats. Lipids Health Dis. 2013;12:136.","journal-title":"Lipids Health Dis"},{"key":"5074_CR52","doi-asserted-by":"publisher","first-page":"977051","DOI":"10.3389\/fimmu.2022.977051","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu L, Zhou Y, Xu J, et al. Anti-inflammatory, antioxidant and anti-virulence roles of atractylodin in attenuating Listeria monocytogenes infection. Front Immunol. 2022;13:977051 (Published 2022 Oct 28).","journal-title":"Front Immunol"},{"key":"5074_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174616","volume":"913","author":"L Chen","year":"2021","unstructured":"Chen L, Tang YL, Liu ZH, Pan Y, Jiao RQ, Kong LD. Atractylodin inhibits fructose-induced human podocyte hypermotility via anti-oxidant to down-regulate TRPC6\/p-CaMK4 signaling. Eur J Pharmacol. 2021;913:174616.","journal-title":"Eur J Pharmacol"},{"key":"5074_CR54","doi-asserted-by":"publisher","first-page":"174010","DOI":"10.1016\/j.ejphar.2021.174010","volume":"899","author":"S Bunbupha","year":"2021","unstructured":"Bunbupha S, Prasarttong P, Poasakate A, Maneesaib P, Pakdeechote P. Imperatorin alleviates metabolic and vascular alterations in high-fat\/high-fructose diet-fed rats by modulating adiponectin receptor 1, eNOS, and p47phox expression. Eur J Pharmacol. 2021;899:174010.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5074_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12986-022-00659-3","volume":"19","author":"J Jin","year":"2022","unstructured":"Jin J, Liu J, Luo Y, He H, Zheng X, Zheng C, Huang Y, Chen Y. High fructose induces dysfunctional vasodilatation via PP2A-mediated eNOS Ser1177 dephosphorylation. Nutr Metab (Lond). 2022;19(1): 24.","journal-title":"Nutr Metab (Lond)"},{"issue":"12","key":"5074_CR56","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/S0026-0495(03)00328-7","volume":"52","author":"CH Kim","year":"2003","unstructured":"Kim CH, Kim MS, Youn JY, Park HS, Song HS, Song KH, Park JY, Lee KU. Lipolysis in skeletal muscle is decreased in high-fat-fed rats. Metabolism. 2003;52(12):1586\u201392.","journal-title":"Metabolism"},{"issue":"3","key":"5074_CR57","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.diabet.2011.01.002","volume":"37","author":"B Antuna-Puente","year":"2011","unstructured":"Antuna-Puente B, Disse E, Rabasa-Lhoret R, Laville M, Capeau J, Bastard JP. How can we measure insulin sensitivity\/resistance? Diabetes Metab. 2011;37(3):179\u201388.","journal-title":"Diabetes Metab"},{"issue":"2","key":"5074_CR58","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1590\/2359-3997000000169","volume":"60","author":"LC Antunes","year":"2016","unstructured":"Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC. Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrinol Metab. 2016;60(2):138\u201342.","journal-title":"Arch Endocrinol Metab"},{"issue":"4","key":"5074_CR59","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1210\/en.2002-220835","volume":"144","author":"V Prpic","year":"2003","unstructured":"Prpic V, Watson PM, Frampton IC, Sabol MA, Jezek GE, Gettys TW. Differential mechanisms and development of leptin resistance in A\/J versus C57BL\/6J mice during diet-induced obesity. Endocrinology. 2003;144(4):1155\u201363.","journal-title":"Endocrinology"},{"issue":"1","key":"5074_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-022-01654-6","volume":"21","author":"H Lu","year":"2022","unstructured":"Lu H, Lei X, Winkler R, John S, Kumar D, Li W, Alnouti Y. Crosstalk of hepatocyte nuclear factor 4a and glucocorticoid receptor in the regulation of lipid metabolism in mice fed a high-fat-high-sugar diet. Lipids Health Dis. 2022;21(1): 46.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"5074_CR61","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1345\/aph.1C197","volume":"37","author":"SF Gardner","year":"2003","unstructured":"Gardner SF, Franks AM. Olmesartan medoxomil: the seventh angiotensin receptor antagonist. Ann Pharmacother. 2003;37(1):99\u2013105.","journal-title":"Ann Pharmacother"},{"issue":"9","key":"5074_CR62","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/01.CIR.0000140265.21608.8E","volume":"110","author":"D Fliser","year":"2004","unstructured":"Fliser D, Buchholz K, Haller H, EUropean. Trial on Olmesartan and Pravastatin in inflammation and atherosclerosis (EUTOPIA) investigators. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation. 2004;110(9):1103\u20137.","journal-title":"Circulation"},{"issue":"3","key":"5074_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/a-2244-3136","volume":"74","author":"L Rind","year":"2024","unstructured":"Rind L, Mahmood T, Siddiqui MH, et al. From hypertension to beyond: unraveling the diverse mechanisms of Olmesartan in disease modulation. Drug Res (Stuttg). 2024;74(3):93\u20131016.","journal-title":"Drug Res (Stuttg)"},{"issue":"Supplement_2","key":"5074_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/ehaa946.2775","volume":"41","author":"K Yushko","year":"2020","unstructured":"Yushko K, Koval S, Snihurska I. Olmesartan improves left ventricular hypertrophy in patients with hypertension and type 2 diabetes with low angiotensin-(1\u20137) blood levels. Eur Heart J. 2020;41(Supplement_2): ehaa946.2775.","journal-title":"Eur Heart J"},{"issue":"7","key":"5074_CR65","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1002\/jssc.201501279","volume":"39","author":"HD Cho","year":"2016","unstructured":"Cho HD, Kim U, Suh JH, Eom HY, Kim J, Lee SG, et al. Classification of the medicinal plants of the genus Atractylodes using high-performance liquid chromatography with diode array and tandem mass spectrometry detection combined with multivariate statistical analysis. J Sep Sci. 2016;39(7):1286\u201394.","journal-title":"J Sep Sci"},{"issue":"1","key":"5074_CR66","doi-asserted-by":"publisher","first-page":"21","DOI":"10.4103\/2229-5186.79345","volume":"2","author":"A Shrivastava","year":"2011","unstructured":"Shrivastava A. Methods for the determination of limit of detection and limit of quantitation of the analytical methods. Chron Young Sci. 2011;2(1):21\u20135. https:\/\/doi.org\/10.4103\/2229-5186.79345.","journal-title":"Chron Young Sci"}],"container-title":["BMC Complementary Medicine and Therapies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05074-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12906-025-05074-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12906-025-05074-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T12:13:30Z","timestamp":1759234410000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccomplementalternmed.biomedcentral.com\/articles\/10.1186\/s12906-025-05074-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5074"],"URL":"https:\/\/doi.org\/10.1186\/s12906-025-05074-8","relation":{},"ISSN":["2662-7671"],"issn-type":[{"value":"2662-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"3 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All experimental procedures were conducted in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and were approved by the Institutional Animal Care and Use Committee (IACUC) for Medical Science of Wonkwang University (WKU 22\u201352). All procedures adhered to the relevant ethical regulations, and the necessary permissions were obtained from the appropriate authorities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"338"}}